Hyperinsulinemia, an overlooked clue and potential way forward in metabolic dysfunction-associated steatotic liver disease. Harrison SA, Dubourg J, Knott M, Colca J, et al. Hepatology 2026;83:169-177.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SA, Dubourg J, Knott M, Colca J, et al. Hyperinsulinemia, an overlooked clue and potential way forward in metabolic dysfunction-associated steatotic liver disease. Hepatology 2026;83:169-177.
PMID: 38051957